Bicalutamide design [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2008-03-26 17:32 (6667 d 06:29 ago) – Posting: # 1725
Views: 5,146

Dear Alhas!

❝ can any one suggest the blood sampling points for bicalutamide as the Tmax is around 31.3h (from US RLD label)


OK, you are talking about the active isomer R(-)bicalutamide.

Some points to consider:
You must be able to show descriptively data of the inactive S(+) isomer as well. This complicates things, because the tmax of S(+) is about 4 hours only (and t½ about 22 hours).
Therefore your sampling time points must be able to describe both profiles…
Due to the long half life of R(-) I would go with a parallel study; truncated AUC should do the job pretty well. In one study in 58 subjects we saw a tmax of R(-) in two subjects at 72 hours – to be on the safe side, I would sample until 96 hours.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
364 visitors (0 registered, 364 guests [including 21 identified bots]).
Forum time: 01:02 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5